Uncovering Basic Signaling Mechanisms in NK Cells in Mice and Humans

揭示小鼠和人类 NK 细胞的基本信号传导机制

基本信息

  • 批准号:
    8878729
  • 负责人:
  • 金额:
    $ 45.47万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2014
  • 资助国家:
    美国
  • 起止时间:
    2014-07-15 至 2017-06-30
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Natural Killer (NK) cells are lymphocytes of the innate immune system that defend us by lysing tumor and pathogen-infected cells. Recent experiments showed generation of long-lived "memory" NK cells in mouse and humans challenged by viral infections (such as CMV), similar to that of memory lymphocytes in the adaptive immune system. We seek to develop a quantitative mechanistic framework with predictive powers for signaling and activation in NK cells including "memory" NK cells in mice and humans by using a synergistic combination of in silico modeling and wet lab experiments. The in silico modeling rooted in statistical physics, non-linear dynamics, and multivariate statistics will be combined with standard biochemical and multi-parametric single cell mass cytometry (CyTOF mass cytometer) experiments on engineered human NK cell lines (NKLs), and naive and "memory" NK cells from mice and humans. We will investigate three overlapping aims: Aim 1: Develop a quantitative mechanistic framework for analyzing signaling and activation of NK cells stimulated by activating and inhibitory CMV-encoded ligands. Aim 2: Determine differences in signaling mechanisms between naive and "memory" NK cells in the mouse. Aim 3: Determine differences in signaling mechanisms between mouse and human "memory" NK cells. At the successful completion of the aims we will have a quantitative predictive mechanistic framework for studying NK cell signaling in mice and humans. The systems level knowledge gained from the proposed projects can also be applied in understanding mechanisms of activation regulated by heterogeneous receptor ligand interactions in other immune cells.
描述(由申请人提供):自然杀伤(NK)细胞是先天免疫系统的淋巴细胞,通过溶解肿瘤和病原体感染的细胞来保护我们。最近的实验表明,在病毒感染(如CMV)的小鼠和人类中产生长寿的“记忆”NK细胞,类似于适应性免疫系统中的记忆淋巴细胞。我们试图通过使用计算机模拟和湿实验室实验的协同组合,开发一种定量机制框架,该框架具有对小鼠和人类NK细胞(包括“记忆”NK细胞)中信号传导和活化的预测能力。植根于统计物理学、非线性动力学和多变量统计学的计算机模拟建模将与标准生物化学和多参数单细胞质量细胞计数(CyTOF质量细胞计数器)实验相结合,该实验对工程化的人NK细胞系(NKL)以及来自小鼠和人的幼稚和“记忆”NK细胞进行。我们将研究三个重叠的目标:目标1:开发一个定量机制框架,用于分析激活和抑制CMV编码的配体刺激的NK细胞的信号传导和激活。目的2:确定小鼠中幼稚和“记忆”NK细胞之间信号传导机制的差异。目的3:确定小鼠和人类“记忆”NK细胞之间信号传导机制的差异。在目标的成功完成,我们将有一个定量的预测机制框架,研究小鼠和人类的NK细胞信号。从所提出的项目中获得的系统级知识也可以应用于理解其他免疫细胞中由异质性受体配体相互作用调节的激活机制。

项目成果

期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Spatial Clustering of Receptors and Signaling Molecules Regulates NK Cell Response to Peptide Repertoire Changes.
受体和信号分子的空间聚集调节 NK 细胞对肽库变化的反应。
  • DOI:
    10.3389/fimmu.2019.00605
  • 发表时间:
    2019
  • 期刊:
  • 影响因子:
    7.3
  • 作者:
    Mbiribindi,Berenice;Mukherjee,Sayak;Wellington,Dannielle;Das,Jayajit;Khakoo,SalimI
  • 通讯作者:
    Khakoo,SalimI
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Jayajit Das其他文献

Jayajit Das的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Jayajit Das', 18)}}的其他基金

Modeling Antibody-induced Immune Responses by NK cells in Mice and Humans (Resubmission 1)
模拟小鼠和人类 NK 细胞抗体诱导的免疫反应(重新提交 1)
  • 批准号:
    10328950
  • 财政年份:
    2020
  • 资助金额:
    $ 45.47万
  • 项目类别:
Modeling Antibody-induced Immune Responses by NK cells in Mice and Humans (Resubmission 1)
模拟小鼠和人类 NK 细胞抗体诱导的免疫反应(重新提交 1)
  • 批准号:
    10112823
  • 财政年份:
    2020
  • 资助金额:
    $ 45.47万
  • 项目类别:
Modeling Antibody-induced Immune Responses by NK cells in Mice and Humans (Resubmission 1)
模拟小鼠和人类 NK 细胞抗体诱导的免疫反应(重新提交 1)
  • 批准号:
    10764466
  • 财政年份:
    2020
  • 资助金额:
    $ 45.47万
  • 项目类别:
Developing a predictive in silico toolkit for modeling NK cell responses against RNA virus infections
开发模拟 NK 细胞针对 RNA 病毒感染反应的预测工具包
  • 批准号:
    10686795
  • 财政年份:
    2019
  • 资助金额:
    $ 45.47万
  • 项目类别:
Developing a predictive in silico toolkit for modeling NK cell responses against RNA virus infections
开发模拟 NK 细胞针对 RNA 病毒感染反应的预测工具包
  • 批准号:
    10246263
  • 财政年份:
    2019
  • 资助金额:
    $ 45.47万
  • 项目类别:
Quantitative Determination of Ecological Niches for Polymicrobial Colonization in
多种微生物定植的生态位的定量测定
  • 批准号:
    9193639
  • 财政年份:
    2014
  • 资助金额:
    $ 45.47万
  • 项目类别:
Quantitative Determination of Ecological Niches for Polymicrobial Colonization in
多种微生物定植的生态位的定量测定
  • 批准号:
    8605790
  • 财政年份:
    2014
  • 资助金额:
    $ 45.47万
  • 项目类别:
A computational model to uncover basic signaling mechanisms of NK cell activation
揭示 NK 细胞激活基本信号机制的计算模型
  • 批准号:
    8434574
  • 财政年份:
    2012
  • 资助金额:
    $ 45.47万
  • 项目类别:

相似海外基金

University of Aberdeen and Vertebrate Antibodies Limited KTP 23_24 R1
阿伯丁大学和脊椎动物抗体有限公司 KTP 23_24 R1
  • 批准号:
    10073243
  • 财政年份:
    2024
  • 资助金额:
    $ 45.47万
  • 项目类别:
    Knowledge Transfer Partnership
Role of Natural Antibodies and B1 cells in Fibroproliferative Lung Disease
天然抗体和 B1 细胞在纤维增生性肺病中的作用
  • 批准号:
    10752129
  • 财政年份:
    2024
  • 资助金额:
    $ 45.47万
  • 项目类别:
CAREER: Next-generation protease inhibitor discovery with chemically diversified antibodies
职业:利用化学多样化的抗体发现下一代蛋白酶抑制剂
  • 批准号:
    2339201
  • 财政年份:
    2024
  • 资助金额:
    $ 45.47万
  • 项目类别:
    Continuing Grant
Isolation and characterisation of monoclonal antibodies for the treatment or prevention of antibiotic resistant Acinetobacter baumannii infections
用于治疗或预防抗生素耐药鲍曼不动杆菌感染的单克隆抗体的分离和表征
  • 批准号:
    MR/Y008693/1
  • 财政年份:
    2024
  • 资助金额:
    $ 45.47万
  • 项目类别:
    Research Grant
Developing first-in-class aggregation-specific antibodies for a severe genetic neurological disease
开发针对严重遗传神经系统疾病的一流聚集特异性抗体
  • 批准号:
    10076445
  • 财政年份:
    2023
  • 资助金额:
    $ 45.47万
  • 项目类别:
    Grant for R&D
Discovery of novel nodal antibodies in the central nervous system demyelinating diseases and elucidation of the mechanisms through an optic nerve demyelination model
发现中枢神经系统脱髓鞘疾病中的新型节点抗体并通过视神经脱髓鞘模型阐明其机制
  • 批准号:
    23K14783
  • 财政年份:
    2023
  • 资助金额:
    $ 45.47万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Elucidation of the mechanisms controlling the physicochemical properties and functions of supercharged antibodies and development of their applications
阐明控制超电荷抗体的理化性质和功能的机制及其应用开发
  • 批准号:
    23KJ0394
  • 财政年份:
    2023
  • 资助金额:
    $ 45.47万
  • 项目类别:
    Grant-in-Aid for JSPS Fellows
Role of antibodies in hepatitis E virus infection
抗体在戊型肝炎病毒感染中的作用
  • 批准号:
    10639161
  • 财政年份:
    2023
  • 资助金额:
    $ 45.47万
  • 项目类别:
Defining the protective or pathologic role of antibodies in Post-Ebola Syndrome
定义抗体在埃博拉后综合症中的保护或病理作用
  • 批准号:
    10752441
  • 财政年份:
    2023
  • 资助金额:
    $ 45.47万
  • 项目类别:
Human CMV monoclonal antibodies as therapeutics to inhibit virus infection and dissemination
人 CMV 单克隆抗体作为抑制病毒感染和传播的治疗药物
  • 批准号:
    10867639
  • 财政年份:
    2023
  • 资助金额:
    $ 45.47万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了